This Article Full Text Full Text (PDF) All Versions of this Article: 19/4/939    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Miller, S. L. Articles by Clevenger, C. V. Search for Related Content PubMed PubMed Citation Articles by Miller, S. L. Articles by Clevenger, C. V.

Novel Association of Vav2 and Nek3 Modulates Signaling through the Human Prolactin Receptor

Department of Pathology and Laboratory Medicine (S.L.M., C.V.C.), University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104; Guilford Pharmaceuticals (J.E.D.), Baltimore, Maryland 21224; Lynchburg College (D.O.F.), Lynchburg, Virginia 24501; and Philadelphia College of Osteopathic Medicine (A.M.R.), Philadelphia, Pennsylvania 19131

Address all correspondence and requests for reprints to: Charles V. Clevenger, University of Pennsylvania Medical Center, 513 Stellar Chance Laboratories, 422 Curie Boulevard, Philadelphia, Pennsylvania 19104. E-mail: clevengc{at}mail.med.upenn.edu.

Prolactin (PRL) receptor activation contributes to the progression and motility of human breast cancer. This event activates multimeric signaling pathways, including the activation of the Vav family of guanine nucleotide exchange factors. To detect novel proteins interacting with Vav, yeast two-hybrid analysis was performed and demonstrated an interaction between the serine/threonine NIMA (never in mitosis A)-related family kinase p56^Nek3 and Vav1. The PRL-dependent interaction of Nek3 with Vav1 and Vav2 was confirmed by coimmunoprecipitation analysis. PRL stimulation of T47D cells induced Nek3 kinase activity and the interaction of Vav2/Nek3 with the PRL receptor. Increased Nek3 levels up-regulated Vav2 serine and tyrosine phosphorylation, whereas knockdown of Nek3 resulted in a reduction of Vav2 phosphorylation. Activation of guanosine triphosphatase Rac-1 in Chinese hamster ovary transfectants required both Nek3 and Vav2 and was inhibited by the overexpression of a kinase inactivating Nek3 mutant. However, overexpression of either Nek3 or kinase-inactive Nek3 had no effect on Vav2-potentiated signal transducer and activator of transcription 5-mediated gene expression. Overexpression of kinase inactive Nek3 in T47D cells led to a 50% increase in apoptosis vs. controls. These data suggest that the PRL-mediated activation of Nek3 contributes differentially to Vav2 signaling pathways involving Rac1 and signal transducer and activator of transcription 5 and implicates Nek3 during PRL-mediated actions in breast cancer.

This article has been cited by other articles:

				C. Leon, D. Nandan, M. Lopez, A. Moeenrezakhanlou, and N. E. Reiner Annexin V Associates with the IFN-{gamma} Receptor and Regulates IFN-{gamma} Signaling J. Immunol., May 15, 2006; 176(10): 5934 - 5942. [Abstract] [Full Text] [PDF]

				L. M. Quarmby and M. R. Mahjoub Caught Nek-ing: cilia and centrioles J. Cell Sci., November 15, 2005; 118(22): 5161 - 5169. [Abstract] [Full Text] [PDF]